Essa Pharma Inc Reports Results For The Quarter Ended In March: Earnings Summary

ESSA Pharma

10/05/2022 14:18

* ESSA Pharma Inc  EPIX.OQ  reported a quarterly adjusted
loss
of 25 cents​​ per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss
of 25 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * ESSA Pharma Inc's reported EPS for the quarter was a loss
of 25
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * ESSA Pharma Inc shares had fallen by 9.4% this quarter and
lost 60.6% so far this year.
    * The company reported a quarterly loss of $10.85 million.
    * Wall Street's median 12-month price target for ESSA Pharma
Inc
is $40.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 10 at 01:17 p.m.  ​All
figures in US dollars unless otherwise stated